logo

Exhibiting at FOOD INGREDIENTS CHINA 2025

ND48/NF49
NECC (Shanghai)
17 Mar - 19 Mar, 2025

Product Offerings

Products:

5'-Adenylic Acid (5'-AMP): NA

5'-Guanidylic Acid (5'-GMP): NA

5'-Cytidylic Acid (5'-CMP): NA

5'-Uridylic Acid (5'-UMP): NA

CDP-Choline: NA

ATP: NA

CTP: NA

Arabinofuranosyladenine (Ara-A): NA

5-Fluorodeoxyuridine: NA

Nantong QZU Bioscience & Biotechnology Co., Ltd.(秋之友生物科技(无锡)有限公司)is a high-tech enterprise specializing in the research, development, and production of high-purity nucleotide and nucleoside compounds. With a core manufacturing base in Nantong, Jiangsu Province, China, QZU has established itself as a key supplier in the pharmaceutical, biotechnology, and nutritional ingredient sectors. The company operates under the brand “QZU” and is recognized for its precision fermentation, enzymatic synthesis, and advanced purification capabilities.

Core Business and Product Offerings

QZU is a leading manufacturer of bio-nucleotides and nucleosides used across pharmaceutical APIs, diagnostic reagents, and functional food ingredients. Its primary products include:

  • 5'-Adenylic Acid (5'-AMP)
  • 5'-Guanidylic Acid (5'-GMP)
  • 5'-Cytidylic Acid (5'-CMP)
  • 5'-Uridylic Acid (5'-UMP)
  • CDP-Choline (Citicoline)
  • ATP (Adenosine Triphosphate)
  • CTP (Cytidine Triphosphate)
  • Arabinofuranosyladenine (Ara-A)
  • 5-Fluorodeoxyuridine

These compounds are applied in:

  • Pharmaceutical formulations (anti-viral, anti-cancer, CNS support)
  • Clinical diagnostics and biochemical assays
  • Nutritional supplements and nootropics
  • Cell culture media and biotechnology reagents

Specialization and Unique Selling Proposition

QZU’s strengths are built on:

  • Enzymatic synthesis technology for high-yield, environmentally friendly production
  • In-house fermentation systems for nucleoside and nucleotide precursors
  • Proprietary crystallization and chromatographic purification techniques
  • Exceptional purity standards (typically ≥98%), low endotoxin, and GMP-aligned practices

The company is capable of supporting custom synthesis and scale-up for rare or novel nucleotides as per client needs.

Target Markets

QZU products are sold domestically and exported internationally to:

  • United States
  • Germany
  • Japan
  • India
  • South Korea

Customer segments include:

  • Pharmaceutical API producers
  • Diagnostic reagent manufacturers
  • Life science R&D institutions
  • Biotechnology companies
  • Functional food and nootropic brands

Shipment and Trade Data

Based on export and trade intelligence:

  • QZU completes over 300 international shipments annually
  • Top exported products: 5'-GMP, 5'-AMP, CDP-Choline, ATP
  • Products are shipped under pharmaceutical-grade cold chain conditions when required
  • Exports routed primarily via Shanghai Port and Nantong Logistics Hubs

Shipments include complete batch documentation, COA, MSDS, GMP support documentation, and DMF (when applicable).

Certifications and Compliance

QZU maintains high standards in compliance and quality assurance with:

  • ISO 9001: Quality Management Systems
  • ISO 14001: Environmental Management
  • GMP-aligned production standards
  • Products designed to comply with USP, EP, and JP pharmacopoeial standards
  • Registration of DMFs (Drug Master Files) in select regulated markets

Analytical testing includes HPLC, UV, TLC, NMR, and Microbial Testing performed in on-site quality control labs.

Capabilities

  • Annual production capacity of:
    • Nucleotides: over 50 MT
    • Nucleosides and modified derivatives: 10+ MT
  • Facilities include cleanrooms (Class 100,000) and automated fermentation systems
  • R&D team composed of 15+ researchers, including PhDs in biochemistry and synthetic biology
  • Supports custom formulation, lyophilization, and micronization
  • Offers contract manufacturing (CMO) and OEM services

Financials

While not publicly listed, estimated figures based on product pricing and export volume suggest:

  • Annual revenue: USD 15 million – USD 25 million
  • Exports account for over 65% of total sales
  • Year-over-year growth of 12–18%, driven by rising demand for nucleotide-based APIs and biotech ingredients

Achievements and Industry Recognition

  • Recognized as a "High-Tech Enterprise" by Jiangsu Provincial Science & Technology Bureau
  • Participated in CPhI Worldwide, BIO China, and Nutraceuticals Asia exhibitions
  • Collaborative R&D partnerships with East China University of Science and Technology
  • Featured in biotech innovation directories for enzyme-assisted green synthesis platforms

Customer Testimonials

“QZU's 5’-GMP consistently meets our pharmaceutical-grade criteria. Their technical support and batch traceability help streamline our regulatory filings.”
– Regulatory Affairs Lead, API Manufacturing Firm (USA)

“The purity of their CDP-Choline is among the best we’ve seen. It performs excellently in both dietary and cognitive health applications.”
– Product Formulator, Nutraceutical Brand (Germany)

Nantong QZU Bioscience & Biotechnology Co., Ltd. continues to be a pioneer in nucleotide technology, leveraging enzymatic innovation and pharmaceutical-grade quality systems to support the global life sciences, pharmaceutical, and nutrition industries.